Clinical trial
A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral…
NCT00254930 · Janssen-Cilag Ltd., Industry · Completed
Key facts
| NCT number | NCT00254930 |
|---|---|
| Title | A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children |
| Official title | Prospective Trial of Risperdal (Risperidone) Following Psychological Therapy for Challenging Behaviour in Learning Disabled Children |
| Lead sponsor | Janssen-Cilag Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Learning Disorders, Child Behavior Disorders |
| Intervention type | Drug |
| Interventions | risperidone |
| Enrollment | 19 |
| Start date | Sep 1, 2003 |
| Completion | Jun 1, 2006 |
| First posted | Nov 17, 2005 |
| Last update posted | May 20, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: